Bart Peter Leroy (Bart P Leroy)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

Ophthalmic genetics

Biomolecules

Clinical ophthalmology (Auckland, N.Z.)

Human mutation

Ghent University

Universiteit Gent (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ghent University Sep 01 2019

Belgium

Professor of Ophthalmology, Ophthalmic Genetics & Visual Electrophysiology :: Department of Head & Skin

Ghent University Hospital Sep 01 2016

Belgium

Chairman & Head of Department :: Department of Ophthalmology

Children's Hospital of Philadelphia Aug 01 2013

United States

Attending Physician :: Division of Ophthalmology

Ghent University Hospital Oct 01 2001

Belgium

Staff Member :: Ctr for Medical Genetics Ghent

Ghent University Hospital Sep 01 2001

Belgium

Staff Member :: Dept of Ophthalmology

Universiteit Gent Oct 01 2009 - Aug 31 2019

Belgium

Associate Professor :: Dept of Ophthalmology

Education History

Universiteit Gent Jul 06 2006

Belgium

PHD :: Dept of Ophthalmology & Ctr for Medical Genetics

Publications

M Dominik Fischer, Francesca Simonelli, Jayashree Sahni, Frank G Holz, Rainer Maier, Christina Fasser, Andrea Suhner, Daniel P Stiehl, Bee Chen, Isabelle Audo, Bart Peter Leroy, null null
Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study. Biomolecules 14 (1) (2024)
Hélène Dollfus, Marc R Lilien, Pietro Maffei, Alain Verloes, Jean Muller, Giacomo Maria Bacci, Metin Cetiner, Erica L T van den Akker, Monika Grudzinska Pechhacker, Francesco Testa, Didier Lacombe, Marijn F Stokman, Francesca Simonelli, Aurélie Gouronc, Amélie Gavard, Mieke M van Haelst, Jens König, Sylvie Rossignol, Carsten Bergmann, Miriam Zacchia, Bart Peter Leroy, Héléna Mosbah, Albertien M Van Eerde, Djalila Mekahli, Aude Servais, Christine Poitou, Diana Valverde
Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations. European journal of human genetics : EJHG (2024)
Austin D Igelman, Elizabeth White, Alaa Tayyib, Lesley A Everett, Ajoy Vincent, Elise Heon, Christina Zeitz, Michel Michaelides, Omar A Mahroo, Mohamed Katta, Andrew Webster, Markus Preising, Birgit Lorenz, Samer Khateb, Eyal Banin, Dror Sharon, Shahar Luski, Filip Van Den Broeck, Bart Peter Leroy, Elfride De Baere, Sophie Walraedt, Katarina Stingl, Laura Kuehlewein, Susanne Kohl, Milda Reith, Anne Fulton, Aparna Raghuram, Isabelle Meunier, Hélène Dollfus, Tomas S Aleman, Emma C Bedoukian, Erin C O'Neil, Emily Krauss, Andrea L Vincent, Charlotte Jordan, Alessandro Iannaccone, Parveen Sen, Srilekha Sundaramurthy, Soumittra Nagasamy, Irina Balikova, Ingele Casteels, Shyamanga Borooah, Shaden Yassin, Aaron Nagiel, Hillary Schwartz, Xavier Zanlonghi, Irene Gottlob, Rebecca J McLean, Francis L Munier, Andrew Stephenson, Robert Sisk, Robert Koenekoop, Lorri B Wilson, Douglas Fredrick, Dongseok Choi, Paul Yang, Mark Edward Pennesi
Characterising the refractive error in paediatric patients with congenital stationary night blindness: a multicentre study. The British journal of ophthalmology (2024)
M Dominik Fischer, Francesca Simonelli, Jayashree Sahni, Frank G Holz, Rainer Maier, Christina Fasser, Andrea Suhner, Daniel P Stiehl, Bee Chen, Isabelle Audo, Bart Peter Leroy, null null
Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study. Biomolecules 14 (1) (2024)
M Dominik Fischer, Francesca Simonelli, Jayashree Sahni, Frank G Holz, Rainer Maier, Christina Fasser, Andrea Suhner, Daniel P Stiehl, Bee Chen, Isabelle Audo, Bart Peter Leroy, null null
Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study. Biomolecules 14 (1) (2024)
M Dominik Fischer, Francesca Simonelli, Jayashree Sahni, Frank G Holz, Rainer Maier, Christina Fasser, Andrea Suhner, Daniel P Stiehl, Bee Chen, Isabelle Audo, Bart Peter Leroy, null null
Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study. Biomolecules 14 (1) (2024)
Stephen R Russell, Arlene V Drack, Artur V Cideciyan, Samuel G Jacobson, Bart Peter Leroy, Caroline Van Cauwenbergh, Allen C Ho, Alina V Dumitrescu, Ian C Han, Mitchell Martin, Wanda L Pfeifer, Elliott H Sohn, Jean Walshire, Alexandra V Garafalo, Arun Kumar Krishnan, Christian A Powers, Alexander Sumaroka, Alejandro J Roman, Eva Vanhonsebrouck, Eltanara Jones, Fanny Nerinckx, Julie De Zaeytijd, Rob W J Collin, Carel Hoyng, Peter Adamson, Michael E Cheetham, Michael R Schwartz, Wilhelmina den Hollander, Friedrich Asmus, Gerard Platenburg, David Rodman, Aniz Girach
Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b/2 trial. Nature medicine 28 (5) (2022)
Elisa Marziali, Filip Van Den Broeck, Sara Bargiacchi, Pina Fortunato, Roberto Caputo, Andrea Sodi, Julie De Zaeytijd, Vittoria Murro, Dario Pasquale Mucciolo, Dario Giorgio, Ilaria Passerini, Viviana Palazzo, Peluso Francesca, Elfriede De Baere, Christina Zeitz, Bart Peter Leroy, Jacopo Secci, Giacomo M Bacci
Optic nerve involvement in CACNA1F -related disease: observations from a multicentric case series. Ophthalmic genetics (2022)
Tomas S Aleman, Erin C O'Neil, Katherine E Uyhazi, Kelsey M Parchinski, Arlene J Santos, Mariejel L Weber, Sherice P Colclough, Andrew S Billek, Xiaosong Zhu, Bart Peter Leroy, Emma C Bedoukian
Fleck-like lesions in CEP290-associated leber congenital amaurosis: a case series. Ophthalmic genetics (2022)
Justine Vandeputte, Mattias Van Heetvelde, Caroline Van Cauwenbergh, Sara Seneca, Elfriede De Baere, Bart Peter Leroy, Julie De Zaeytijd
Mild Leber hereditary optic neuropathy (LHON) in a Western European family due to the rare Asian m.14502T>C variant in the MT-ND6 gene. Ophthalmic genetics 42 (4) (2021)
Tomas S Aleman, Alexander J Miller, Katherine H Maguire, Elena M Aleman, Leona W Serrano, Keli B O'Connor, Emma C Bedoukian, Bart Peter Leroy, Albert M Maguire, Jean Bennett
A Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations: Testing a Proof-of-Concept After Gene Therapy. Clinical ophthalmology (Auckland, N.Z.) 15 (2021)
Shaobin Dong, Nicole Tsao, Qiang Hou, Duygu Bozkaya, Bart Peter Leroy
US Health Resource Utilization and Cost Burden Associated with Choroideremia. Clinical ophthalmology (Auckland, N.Z.) 15 (2021)
Tom Van Hoorde, Fanny Nerinckx, Elke Kreps, Dimitri Roels, Philippe Huyghe, Mattias Van Heetvelde, Hannah Verdin, Elfriede De Baere, Irina Balikova, Bart Peter Leroy
Expanding the clinical spectrum and management of Traboulsi syndrome: report on two siblings homozygous for a novel pathogenic variant in ASPH. Ophthalmic genetics 42 (4) (2021)
Julie De Zaeytijd, Frauke Coppieters, Marieke De Bruyne, Jasper Van Royen, Dimitri Roels, Rani Six, Caroline Van Cauwenbergh, Elfriede De Baere, Bart Peter Leroy
Longitudinal phenotypic study of late-onset retinal degeneration due to a founder variant c.562C>A p.(Pro188Thr) in the C1QTNF5 gene. Ophthalmic genetics 42 (5) (2021)
Giulia Ascari, Frank Peelman, Pietro Farinelli, Toon Rosseel, Nina Lambrechts, Kirsten A Wunderlich, Matias Wagner, Konstantinos Nikopoulos, Pernille Martens, Irina Balikova, Lara Derycke, Gabriële Holtappels, Olga Krysko, Thalia Van Laethem, Sarah De Jaegere, Brecht Guillemyn, Teddy Jégu, Jan De Bleecker, David Creytens, Jo Van Dorpe, Jan Gerris, Claus Bachert, Christiane M Neuhofer, Sophie Walraedt, Almut Bischoff, Lotte Bang Pedersen, Florentine Radelfahr, Carlo Rivolta, Bart Peter Leroy, Elfriede De Baere, Frauke Coppieters
Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility. Human mutation 41 (5) (2020)
Sarah Naessens, Julie De Zaeytijd, Delfien Syx, Roosmarijn E. Vandenbroucke, Frédéric Smeets, Caroline Van Cauwenbergh, Bart Peter Leroy, Frank Peelman, Frauke Coppieters
The N-terminal p.(Ser38Cys) TIMP3 mutation underlying Sorsby fundus dystrophy is a founder mutation disrupting an intramolecular disulfide bond. Human mutation 40 (5) (2019)

Bart Peter Leroy.css-eqlu8i{font-size:small;padding-left:4px;} (Bart P Leroy)

Publication Activity (10 Years)

Top Topics

Top Venues

Bart Peter Leroy (Bart P Leroy)